The efficacy of generic imatinib in patients with chronic myeloid leukemia: A single centre experience

Background/Aim. The treatment of chronic myeloid leukemia (CML) has changed dramatically with the advent of targeted therapies. This study aimed to assess the efficacy of generic imatinib in CML patients treated in our center. Methods. The study was retrospective. It included 101 patients diagnosed...

詳細記述

書誌詳細

主要な著者:	Urošević Ivana, Perčić Ivanka, Dragičević-Jojkić Marina, Dokić Marina, El Farra Amir, Savić Aleksandar, Milošević Ivana, Vlaisavljević Nada, Sekulić Borivoj, Balint Bela
フォーマット:	Artigo
言語:	Inglês
出版事項:	Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2021-01-01
シリーズ:	Vojnosanitetski Pregled
主題:	leukemia, myeloid, chronic-phase imatinib mesylate drugs, generic survival
オンライン･アクセス:	http://www.doiserbia.nb.rs/img/doi/0042-8450/2021/0042-84501900095U.pdf
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!